FTC cracks down on DaVita's market power

  • 📰 axios
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 63%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

The Federal Trade Commission has the dialysis industry in its crosshairs after it finalized restrictions on DaVita's latest deal in Utah.

agreement

allows DaVita to purchase 18 dialysis clinics owned by University of Utah Health, but three acquired clinics in the Provo, Utah area must be divested. DaVita also can't buy another clinic in Utah for 10 years unless it gets prior FTC approval, nor can it prevent employees at the acquired clinics from jumping to jobs at competing dialysis clinics.

If the FTC didn't impose these conditions, DaVita would have owned seven of the eight dialysis clinics in the Provo area.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 302. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

日本 最新ニュース, 日本 見出し